CONBRIZA

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

BAZEDOXIFENE AS ACETATE 20 MG

Dostupné s:

NEOPHARM LTD

ATC kód:

G03XC02

Léková forma:

COATED TABLETS

Podání:

PER OS

Výrobce:

PFIZER IRELAND PHARMACEUTICALS

Terapeutické skupiny:

BAZEDOXIFENE

Terapeutické indikace:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Datum autorizace:

2013-04-01